| Literature DB >> 35805197 |
Kamila Duś-Szachniewicz1, Katarzyna Gdesz-Birula1, Emilia Nowosielska2, Piotr Ziółkowski1, Sławomir Drobczyński2.
Abstract
Interactions between stromal and lymphoma cells in the bone marrow are closely related to drug resistance and therapy failure. Physiologically relevant pre-clinical three-dimensional (3D) models recapitulating lymphoma microenvironmental complexity do not currently exist. In this study, we proposed a scheme for optically controlled hybrid lymphoma spheroid formation with the use of optical tweezers (OT). Following the preparation of stromal spheroids using agarose hydrogel, two aggressive non-Hodgkin lymphoma B-cell lines, Ri-1 (DLBCL) and Raji (Burkitt lymphoma), were used to conduct multi-cellular spheroid formation driven by in-house-developed fluorescence optical tweezers. Importantly, the newly formed hybrid spheroid preserved the 3D architecture for the next 24 h. Our model was successfully used for the evaluation of the influence of the anticancer agents doxorubicin (DOX), ibrutinib (IBR), and AMD3100 (plerixafor) on the adhesive properties of lymphoma cells. Importantly, our study revealed that a co-treatment of DOX and IBR with AMD3100 affects the adhesion of B-NHL lymphoma cells.Entities:
Keywords: 3D lymphoma model; AMD3100 (plerixafor); cell adhesion; cell co-culture; doxorubicin (DOX); ibrutinib (IBR); lymphoma–stromal cell crosstalk; optical tweezers; single-cell manipulations
Mesh:
Substances:
Year: 2022 PMID: 35805197 PMCID: PMC9265821 DOI: 10.3390/cells11132113
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Figure 1(A) In-house-developed fluorescence optical tweezers (FOT). L1, …, L4—lenses; DM1, DM2—dichroic mirrors; BS—beam splitter; GMXY—Galvano-mirror XY scanning system; OB—high NA numerical aperture objective; Exc.F—excitation filter; Em.F—emission filter; CAM1, CAM2—digital cameras 1 and 2. (B) The image of a hybrid spheroid taken in the brightfield by CAM1. The red box represents the optical trap. (C) The fluorescent image of a hybrid spheroid was taken by CAM2.
Figure 2The visualization of the stages of the hybrid spheroid formation using OT. (A) A lymphoma cell is trapped by optical tweezers (highlighted by the red box). (B) the lymphoma cell is moved toward the surface of the stromal spheroid, and cell–spheroid contact is initiated. The lymphoma cell is retained in the center of the optical trap until an adhesion junction is formed between the lymphoma cell and the stromal spheroid. (C) Successive cells (indicated by arrows) are attached to the mass of the stromal spheroid. (D–H) The process of attaching subsequent lymphoma cells to the spheroid. (I) A complete hybrid lymphoma–stromal cell spheroid. Images were taken in the brightfield; scale bar = 25 μm.
Figure 3(A) De novo formed hybrid spheroid and (B) a fluorescent image of the spheroid stained with calcein (live cells) 24 h after the re-incubation. (C) Live/dead assay for the viability of the spheroid. Staining was performed immediately (0 h) and one day (24 h) after manipulations with calcein (live cells) and propidium iodide (dead cells). Quantification of the live/dead assay was performed using ImageJ software. An index of live lymphoma cells (% of cell viability) was constructed from the ratio of lived to the total cell numbers.
Figure 4The effect of the anticancer treatment on the adhesion of Ri-1 (A) and RAJI (B) cell lines to the stromal spheroid evaluated in OT. Error bars represent the standard error of the mean calculated from three independent measurements. DOX, doxorubicin; IBR, ibrutinib. * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001.